Rating History for Dicerna Pharmaceuticals (DRNA) by RBC Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/19/2021 | Luca Issi | Downgrade | Sector Perform (Outperform) |
38.25 (30.00) |
21.28 (38.22) |
79.61% | Details |
 |
|||||||
|
|||||||
